PXAI Audio Feed
23/04 21:05 statnews.com

STAT+: Trump’s boosting of psychedelics, cannabis signals a new era in GOP drug policy

CHRONIC DISEASESHEALTHADDICTIONHHSRESEARCHMENTAL HEALTH
22/04 11:30 statnews.com

Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush

CHRONIC DISEASEPUBLIC HEALTHPOLITICSRFK JR.HEALTH
21/04 14:00 statnews.com

STAT+: BioAge says experimental pill aimed at reducing heart risks significantly reduced inflammation

CARDIOVASCULAR DISEASECHRONIC DISEASEPHARMACEUTICALSSTAT+DRUG DEVELOPMENTBIOTECHNOLOGY
21/04 14:00 statnews.com

STAT+: Tortugas Neuroscience launches with hopes to develop drugs for brain disorders, other conditions

MENTAL HEALTHCHRONIC DISEASEPHARMACEUTICALSSTAT+DRUG DEVELOPMENTEXCLUSIVE
17/04 12:00 statnews.com

STAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows

STAT+POLITICSIN THE LABHEALTHCHRONIC DISEASESEARTHQUAKE
16/04 13:30 statnews.com

STAT+: Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway

STAT+CHRONIC DISEASEPHARMACEUTICALSDRUG DEVELOPMENTADAM'S TAKEPOLITICS
15/04 16:30 statnews.com

STAT+: FDA panel will meet to discuss allowing broader access to certain peptides

HEALTHDIPLOMACYCHRONIC DISEASEFDARFK JR.STAT+
15/04 14:00 statnews.com

STAT+: New Bain biotech startup, building on BMS drugs, gets a name and a CEO

PHARMACEUTICALSBIOTECHBIOTECHNOLOGYSTAT+CHRONIC DISEASEDRUG DEVELOPMENT
13/04 14:00 statnews.com

STAT+: Spyre Therapeutics IBD drug shows promise in early trial

POLITICSSTAT+BIOTECHNOLOGYBIOTECHCHRONIC DISEASESDRUG DEVELOPMENT
13/04 14:00 statnews.com

STAT+: Spyre Therapeutics IBD drug shows promise in early trial

POLITICSSTAT+BIOTECHNOLOGYBIOTECHCHRONIC DISEASESDRUG DEVELOPMENT
Comments
Loading...
0